Notification
No new Notification messages
Zinka Logistics Solutions IPO is Open!
Apply for the Zinka Logistics Solutions IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
valiant laboratories ltd stock

VALIANT LABORATORIES LTD Share Price

110.53 0.52 (0.47%)
Nov 21 2024 03:29 PM Pharmaceuticals NSE: VALIANTLAB

VALIANT LABORATORIES LTD Share Price Update

As of the latest trading session, VALIANT LABORATORIES LTD share price is currently at 110.53, which is up by 0.52 from its previous closing. Today, the stock has fluctuated between 107.96 and 112.15. Over the past year, VALIANT LABORATORIES LTD has achieved a return of -40.36 %. In the last month alone, the return has been -2.23 %. Read More...

VALIANT LABORATORIES LTD Performance

Day Range

Low107.96 High112.15
110.58

52 Week Range

Low 100.20 High 214.95
110.58

VALIANT LABORATORIES LTD Share Price

19218

543998

VALIANTLAB

img img img img
No Data Available

Open Price

112.15

Prev. Close

110.00

Volume (Shares)

152347.00

Total traded value

168.46

Upper Circuit

132.00

Lower Circuit

88.00

Note: The current prices & values are delayed, Login to your account for live updates.

VALIANT LABORATORIES LTD Fundamentals


(Standalone)

Market Cap (Cr) 480.25
PE Ratio (TTM) -40.89
Book Value / Share 52.90
Beta 1.19
ROE -1.70%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -5.98

VALIANT LABORATORIES LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 21.48
Operating Expense 28.74
Net Profit -5.98
Net Profit Margin (%) -27.83
Earnings Per Share (EPS) -1.39
EBITDA -4.80
Effective Tax Rate (%) -12.40
Particulars JUN 2024 (Values in Cr)
Revenue 18.88
Operating Expense 21.83
Net Profit -1.01
Net Profit Margin (%) -5.34
Earnings Per Share (EPS) -0.23
EBITDA -0.21
Effective Tax Rate (%) -29.87
Particulars MAR 2024 (Values in Cr)
Revenue 30.58
Operating Expense 35.64
Net Profit -1.22
Net Profit Margin (%) -3.98
Earnings Per Share (EPS) -0.32
EBITDA -2.03
Effective Tax Rate (%) 52.15
Particulars DEC 2023 (Values in Cr)
Revenue 40.52
Operating Expense 47.34
Net Profit -3.50
Net Profit Margin (%) -8.63
Earnings Per Share (EPS) -0.81
EBITDA -4.53
Effective Tax Rate (%) 30.55
Particulars SEP 2023 (Values in Cr)
Revenue 59.55
Operating Expense 61.44
Net Profit 0.79
Net Profit Margin (%) 1.32
Earnings Per Share (EPS) 0.24
EBITDA 1.57
Effective Tax Rate (%) 25.47
Particulars MAR 2024 (Values in Cr)
Revenue 182.05
Operating Expense 192.49
Net Profit 0.34
Net Profit Margin (%) 0.18
Earnings Per Share (EPS) 0.14
EBITDA 1.27
Effective Tax Rate (%) 145.33
Particulars MAR 2023 (Values in Cr)
Revenue 333.91
Operating Expense 300.63
Net Profit 29.00
Net Profit Margin (%) 8.68
Earnings Per Share (EPS) 8.91
EBITDA 39.95
Effective Tax Rate (%) 23.96
Particulars MAR 2022 (Values in Cr)
Revenue 291.52
Operating Expense 251.76
Net Profit 27.50
Net Profit Margin (%) 9.43
Earnings Per Share (EPS) 16.99
EBITDA 44.26
Effective Tax Rate (%) 34.07
Particulars MAR 2024 (Values in Cr)
Book Value / Share 54.51
ROE % -1.71
ROCE % -1.63
Total Debt to Total Equity 0.41
EBITDA Margin -1.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 30.86
ROE % 28.86
ROCE % 23.73
Total Debt to Total Equity 0.60
EBITDA Margin 11.96
Particulars MAR 2024 (Values in Cr)
Book Value / Share 54.52
ROE % -1.70
ROCE % -1.68
Total Debt to Total Equity 0.36
EBITDA Margin -1.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 30.86
ROE % 33.73
ROCE % 26.00
Total Debt to Total Equity 0.71
EBITDA Margin 11.96
Particulars MAR 2022 (Values in Cr)
Book Value / Share 43.89
ROE % 34.37
ROCE % 37.35
Total Debt to Total Equity 0.39
EBITDA Margin 15.18
Particulars MAR 2021 (Values in Cr)
Book Value / Share 84.36
ROE % 34.53
ROCE % 54.13
Total Debt to Total Equity 0.01
EBITDA Margin 28.19
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 106.21
Total Assets 342.68
Total Liabilities 342.68
Total Equity 236.86
Share Outstanding 43450000
Price to Book Ratio 2.67
Return on Assets (%) 0.09
Return on Capital (%) 0.1
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.34
Total Assets 212.96
Total Liabilities 212.96
Total Equity 100.49
Share Outstanding 32560000
Price to Book Ratio 0.00
Return on Assets (%) 13.61
Return on Capital (%) 18.14
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 96.72
Total Assets 324.72
Total Liabilities 324.72
Total Equity 236.88
Share Outstanding 43450000
Price to Book Ratio 2.67
Return on Assets (%) 0.10
Return on Capital (%) 0.11
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.45
Total Assets 212.75
Total Liabilities 212.75
Total Equity 100.49
Share Outstanding 32560000
Price to Book Ratio 0.00
Return on Assets (%) 13.62
Return on Capital (%) 18.14
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 20.13
Total Assets 181.81
Total Liabilities 181.81
Total Equity 71.46
Share Outstanding 16280000
Price to Book Ratio 0.00
Return on Assets (%) 15.12
Return on Capital (%) 20.81
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 18.93
Total Assets 106.31
Total Liabilities 106.31
Total Equity 88.58
Share Outstanding 10500000
Price to Book Ratio 0.00
Return on Assets (%) 28.77
Return on Capital (%) 34.4
Particulars MAR 2024 (Values in Cr)
Net Income -0.76
Cash from Operations 0.90
Cash from Investing -143.87
Cash from Financing 152.44
Net change in Cash 10.45
Free Cash Flow 46.77
Particulars MAR 2023 (Values in Cr)
Net Income 38.13
Cash from Operations 64.85
Cash from Investing -55.16
Cash from Financing -0.93
Net change in Cash -0.05
Free Cash Flow 102.53
Particulars MAR 2024 (Values in Cr)
Net Income -0.75
Cash from Operations 47.80
Cash from Investing -182.72
Cash from Financing 135.79
Net change in Cash 1.85
Free Cash Flow 51.55
Particulars MAR 2023 (Values in Cr)
Net Income 38.13
Cash from Operations 31.75
Cash from Investing -21.17
Cash from Financing -1.53
Net change in Cash 0.24
Free Cash Flow 38.82
Particulars MAR 2022 (Values in Cr)
Net Income 41.70
Cash from Operations 16.71
Cash from Investing -12.23
Cash from Financing 6.18
Net change in Cash -3.80
Free Cash Flow 23.59
Particulars MAR 2021 (Values in Cr)
Net Income 47.02
Cash from Operations 25.56
Cash from Investing -16.66
Cash from Financing 11.42
Net change in Cash 3.86
Free Cash Flow 27.23
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 55.85 32.10 3.04 428.00 37.54 / 77.70
BLISS GVS PHARMA LTD 120.75 15.11 1.25 1271.52 92.25 / 148.95
CIPLA LTD 1471.35 25.74 4.18 118825.56 1165.10 / 1702.00
FERMENTA BIOTECH LIMITED 331.20 115.00 3.35 974.75 145.00 / 354.60
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 55.85 48.57 9.49 428.00 37.54 / 77.70
AMRUTAJAN HEALTH LTD 720.90 43.85 6.99 2084.17 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6497.50 126.19 23.91 16243.75 4050.15 / 8139.85
BLISS GVS PHARMA LTD 120.75 15.72 1.24 1271.52 92.25 / 148.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 110.40
  • 26 Days 112.80
  • 10 Days 111.70
  • 50 Days 116.50
  • 12 Days 112.50
  • 100 Days 121.00
  • 20 Days 112.20
  • 200 Days 192.20
109.98
PIVOT
First Resistance 111.52
Second Resistance 113.04
Third Resistance 114.58
First Support 108.46
Second Support 106.92
Third Support 105.40
RSI 47.33
MACD -0.34
Commodity Channel Index (CCI) -56.54
ADX 11.41
Williams % R -59.63

Over 1 Month

down

-2.23

Over 3 Months

down

1.71

Over 6 Months

down

-23.55

Over 1 Year

down

-40.36

Over 3 Years

down

0.00

Over 5 Years

down

0.00

VALIANT LABORATORIES LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

VALIANT LABORATORIES LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
25.06
Promoter Holdings
74.93
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Dhanvallabh Ventures Llp Shareholding of Promoter and Promoter Group 2.035E7 46.84
Paresh Shashikant Shah Shareholding of Promoter and Promoter Group 4067690.0 9.36
Shantilal Shivji Vora Shareholding of Promoter and Promoter Group 3259190.0 7.5
Santosh Shantilal Vora Shareholding of Promoter and Promoter Group 3259190.0 7.5
Kanchan Shantilal Vora Shareholding of Promoter and Promoter Group 1614690.0 3.72
Jainam Broking Limited Public Shareholding 678089.0 1.56
Priyanka Shwetkumar Koradiya Public Shareholding 510000.0 1.17
Rachi Santosh Vora Shareholding of Promoter and Promoter Group 6930.0 0.02
Varsha Paresh Shah Shareholding of Promoter and Promoter Group 2310.0 0.01
Sangita Manoj Jain Shareholding of Promoter and Promoter Group 1000.0 0.0

VALIANT LABORATORIES LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About VALIANT LABORATORIES LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by VALIANT LABORATORIES LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Valiant Laboratories Ltd?

Answer Field

The share price of Valiant Laboratories Ltd for NSE is ₹ 110.53 and for BSE is ₹ 109.9.

What is the Market Cap of Valiant Laboratories Ltd?

Answer Field

The market cap of Valiant Laboratories Ltd for NSE is ₹ 4,80.25 Cr. and for BSE is ₹ 4,77.51 Cr. as of now.

What is the 52 Week High and Low of Valiant Laboratories Ltd?

Answer Field

The 52 Week High and Low of Valiant Laboratories Ltd for NSE is ₹ 214.95 and ₹ 100.20 and for BSE is ₹ 226.95 and ₹ 99.90.

How to Buy Valiant Laboratories Ltd share?

Answer Field

You can trade in Valiant Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Valiant Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been -40.36%.

What is the Current Share Price of Valiant Laboratories Ltd?

Answer Field

Valiant Laboratories Ltd share price is for NSE ₹ 110.53 & for BSE ₹ 109.9 as on Nov 21 2024 03:29 PM.

What is the Market Cap of Valiant Laboratories Ltd Share?

Answer Field

The market cap of Valiant Laboratories Ltd for NSE ₹ 4,80.25 & for BSE ₹ 4,77.51 as on Nov 21 2024 03:29 PM.

What is the P/E Ratio of Valiant Laboratories Ltd Share?

Answer Field

As on Nov 21 2024 03:29 PM the price-to-earnings (PE) ratio for Valiant Laboratories Ltd share is -40.89.

What is the PB ratio of Valiant Laboratories Ltd Share?

Answer Field

As on Nov 21 2024 03:29 PM, the price-to-book (PB) ratio for Valiant Laboratories Ltd share is 52.90.

How to Buy Valiant Laboratories Ltd Share?

Answer Field

You can trade in Valiant Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Valiant Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Valiant Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Valiant Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader